MX2019013161A - Personalized immunotherapy against several neuronal and brain tumors. - Google Patents
Personalized immunotherapy against several neuronal and brain tumors.Info
- Publication number
- MX2019013161A MX2019013161A MX2019013161A MX2019013161A MX2019013161A MX 2019013161 A MX2019013161 A MX 2019013161A MX 2019013161 A MX2019013161 A MX 2019013161A MX 2019013161 A MX2019013161 A MX 2019013161A MX 2019013161 A MX2019013161 A MX 2019013161A
- Authority
- MX
- Mexico
- Prior art keywords
- present
- tumor
- relates
- brain tumors
- against several
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361899680P | 2013-11-04 | 2013-11-04 | |
GBGB1319446.9A GB201319446D0 (en) | 2013-11-04 | 2013-11-04 | Personalized immunotherapy against several neuronal and brain tumors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019013161A true MX2019013161A (en) | 2020-02-03 |
Family
ID=70386385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019013161A MX2019013161A (en) | 2013-11-04 | 2016-05-04 | Personalized immunotherapy against several neuronal and brain tumors. |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP6963836B2 (en) |
MX (1) | MX2019013161A (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2338907T3 (en) * | 2007-07-27 | 2016-03-31 | Immatics Biotechnologies Gmbh | Novel immunogenic epitopes for immunotherapy |
PT2172211E (en) * | 2008-10-01 | 2015-03-09 | Immatics Biotechnologies Gmbh | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers |
GB201319446D0 (en) * | 2013-11-04 | 2013-12-18 | Immatics Biotechnologies Gmbh | Personalized immunotherapy against several neuronal and brain tumors |
-
2016
- 2016-05-04 MX MX2019013161A patent/MX2019013161A/en unknown
-
2019
- 2019-12-11 JP JP2019223500A patent/JP6963836B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP6963836B2 (en) | 2021-11-10 |
JP2020062025A (en) | 2020-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016005866A (en) | Personalized immunotherapy against several neuronal and brain tumors. | |
PH12015502638A1 (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
PH12019502194A1 (en) | Novel immunotherapy against several tumors including gastrointestinal and gastric cancer | |
PH12021551208A1 (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
MA39907A (en) | Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml) | |
WO2015193359A3 (en) | Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (cll) | |
MX338294B (en) | Novel immunotherapy against several tumors including neuronal and brain tumors. | |
MX2010001086A (en) | Novel immunotherapy against neuronal and brain tumors. | |
PH12016502008A1 (en) | Novel immunotherapy against several tumors of the blood, such as acute myeloid lukemia (aml) | |
MX2019013161A (en) | Personalized immunotherapy against several neuronal and brain tumors. | |
MY194653A (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
MY193910A (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
MY194244A (en) | Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc | |
MY194241A (en) | Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including NSCLC | |
EA201990696A1 (en) | PERSONALIZED IMMUNOTHERAPY OF SEVERAL SPECIES OF NEURAL TUMORS AND BRAIN TUMORS | |
EA202090822A2 (en) | A NEW METHOD FOR IMMUNOTHERAPY OF SEVERAL TUMORS OF TUMORS SUCH AS LUNG CANCER, INCLUDING NSCLC |